Litigation Details for ACTELION PHARMACEUTICALS LTD. v. SUN PHARMACEUTICAL INDUSTRIES, INC. (D.N.J. 2017)
✉ Email this page to a colleague
ACTELION PHARMACEUTICALS LTD. v. SUN PHARMACEUTICAL INDUSTRIES, INC. (D.N.J. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-07-07 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | 15:1126 Patent Infringement | Assigned To | |
Jury Demand | Referred To | ||
Patents | 8,318,802; 8,598,227 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in ACTELION PHARMACEUTICALS LTD. v. SUN PHARMACEUTICAL INDUSTRIES, INC.
Details for ACTELION PHARMACEUTICALS LTD. v. SUN PHARMACEUTICAL INDUSTRIES, INC. (D.N.J. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-02-15 | 66 | would result in United States Patent Number 8,318,802 (the ‘802 patent). (Harold Decl., Ex. G, Response…concerning United States Patent No. 8,598,227 (“227 patent”). The ‘227 patent is listed to market and …United States Patent, which ultimately issued as U.S. Patent No. 4,335,139 (“the Watts Patent”). (See Declaration…‘227 patent — in the ‘227 patent and its prosecution history, the ‘802 divisional patent and its…Harold Deci.), Ex. I, United States Patent No. 4,335,139). The Watts patent claims: | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |